These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24905507)

  • 1. Modulation of adenosinergic system and its application for the treatment of epilepsy.
    Świąder MJ; Kotowski J; Łuszczki JJ
    Pharmacol Rep; 2014 Jun; 66(3):335-42. PubMed ID: 24905507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosinergic signaling in epilepsy.
    Boison D
    Neuropharmacology; 2016 May; 104():131-9. PubMed ID: 26341819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of adenosinergic modulation on the anticonvulsant effect of phenobarbitone and carbamazepine.
    Malhotra J; Gupta YK
    Methods Find Exp Clin Pharmacol; 1999 Mar; 21(2):79-83. PubMed ID: 10327387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulators of nucleoside metabolism in the therapy of brain diseases.
    Boison D
    Curr Top Med Chem; 2011; 11(8):1068-86. PubMed ID: 21401494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulatory role of adenosine and its receptors in epilepsy: possible therapeutic approaches.
    Pagonopoulou O; Efthimiadou A; Asimakopoulos B; Nikolettos NK
    Neurosci Res; 2006 Sep; 56(1):14-20. PubMed ID: 16846657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamate metabotropic receptors as targets for drug therapy in epilepsy.
    Moldrich RX; Chapman AG; De Sarro G; Meldrum BS
    Eur J Pharmacol; 2003 Aug; 476(1-2):3-16. PubMed ID: 12969743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine-based cell therapy approaches for pharmacoresistant epilepsies.
    Boison D
    Neurodegener Dis; 2007; 4(1):28-33. PubMed ID: 17429216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the purinergic signaling in epilepsy.
    Cieślak M; Wojtczak A; Komoszyński M
    Pharmacol Rep; 2017 Feb; 69(1):130-138. PubMed ID: 27915186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant effect of AMP by direct activation of adenosine A1 receptor.
    Muzzi M; Coppi E; Pugliese AM; Chiarugi A
    Exp Neurol; 2013 Dec; 250():189-93. PubMed ID: 24056265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the adenosine system in epilepsy and its comorbidities.
    Baltos JA; Casillas-Espinosa PM; Rollo B; Gregory KJ; White PJ; Christopoulos A; Kwan P; O'Brien TJ; May LT
    Br J Pharmacol; 2024 Jul; 181(14):2143-2157. PubMed ID: 37076128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated treatment with adenosine A1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene.
    De Sarro G; Donato Di Paola E; Falconi U; Ferreri G; De Sarro A
    Eur J Pharmacol; 1996 Dec; 317(2-3):239-45. PubMed ID: 8997606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety issues of compounds acting on adenosinergic signalling.
    Schmidt J; Ferk P
    J Pharm Pharmacol; 2017 Jul; 69(7):790-806. PubMed ID: 28397249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine receptors in brain: neuromodulation and role in epilepsy.
    Chin JH
    Ann Neurol; 1989 Dec; 26(6):695-8. PubMed ID: 2690732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of adenosine A1 and A2 receptor stimulation on hypoxia-induced convulsions in adult mice.
    Zgodziński W; Rubaj A; Kleinrok Z; Sieklucka-Dziuba M
    Pol J Pharmacol; 2001; 53(1):83-92. PubMed ID: 11785919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies.
    Boison D
    Neuroscientist; 2005 Feb; 11(1):25-36. PubMed ID: 15632276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy.
    Gouder N; Fritschy JM; Boison D
    Epilepsia; 2003 Jul; 44(7):877-85. PubMed ID: 12823569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosinergic system as an endogenous anticonvulsant mechanism.
    Gupta YK; Malhotra J
    Indian J Physiol Pharmacol; 1997 Oct; 41(4):329-43. PubMed ID: 10235655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting effects of adenosine A1 and A2 receptor ligands in different chemoconvulsive rodent models.
    Klitgaard H; Knutsen LJ; Thomsen C
    Eur J Pharmacol; 1993 Oct; 242(3):221-8. PubMed ID: 7904242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABA release modified by adenosine receptors in mouse hippocampal slices under normal and ischemic conditions.
    Saransaari P; Oja SS
    Neurochem Res; 2005 Apr; 30(4):467-73. PubMed ID: 16076017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
    Klitgaard H; Matagne A; Gobert J; Wülfert E
    Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.